Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia

[at noodls] – – Genzyme to Advance ALN-TTR02 and ALN-TTRsc Programs as Breakthrough Therapies for Patients with ATTR in Japan and in the Broader Asian Market – – Alnylam to Receive $22.5 Million in Upfront Payment in … more

View todays social media effects on ALNY

View the latest stocks trending across Twitter. Click to view dashboard